S2Medical AB Class B

As of December 31, 2024, S2Medical AB Class B carries a market capitalization of 8.84M, placing it among publicly traded companies globally. Its enterprise value stands at 7.84M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2024, S2Medical AB Class B has 1.14B shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, S2Medical AB Class B maintains a current ratio of 0.87, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 23, 2026, S2Medical AB Class B's stock has declined approximately 54.31% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.01.

As of December 31, 2024, S2Medical AB Class B holds 1.00M in cash and equivalents against - - in total debt, resulting in a net debt position of -1.00M. Total book value stands at 18.72M, with working capital of -850,209.00 providing operational flexibility.

These figures cover the twelve months ended December 31, 2024.

S2Medical AB Class B's most recent stock split took place on August 19, 2026 with a 23:31 split ratio.